52 Participants NeededMy employer runs this trial

Smell Training for Loss of Smell

(CIPOD Trial)

JO
CN
Overseen ByChristopher Novicky
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

A research study to assess the baseline olfactory function, mental health status, clinical severity, and immunological profile in patients with smell loss. The impact of a 3-month olfactory training program on smell function, immunological changes, and mental health in patients with smell loss will be evaluated.

The primary purpose of this study is to investigate tissue and blood samples to identify molecules that may be related to smell loss, ultimately aiming to develop future treatments for this condition and correlate with cognition.

Who Is on the Research Team?

MC

Mohamad Chaaban, MD

Principal Investigator

The Cleveland Clinic

Are You a Good Fit for This Trial?

This trial is for people who have lost their sense of smell, including those with nasal or sinus cancer, anomia (trouble naming objects), or sinusitis. Participants should be adults willing to undergo smell training and provide tissue and blood samples.

Inclusion Criteria

I am younger than 18 years old.
I have lost my sense of smell, not due to injury or tumor.
I have chronic sinusitis with nasal polyps.

Exclusion Criteria

I am younger than 18 years old.
I have an autoimmune disease.
I have a diagnosed ciliary disorder.
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • Smell Training

Trial Overview

The study tests whether a 3-month smell training program can improve the sense of smell, immune response, and mental health in people with olfactory loss. Researchers will also analyze tissue and blood samples to find related molecules.

How Is the Trial Designed?

4

Treatment groups

Active Control

Group I: Group 1: - loss of smell + CRS with nasal polyps (CRSwNP)Active Control1 Intervention
Group II: Group 2: - loss of smell with no CRS/no polyps - undergo 3 months of smell trainingActive Control1 Intervention
Group III: Control Group 1: - no loss of smell CRS with nasal polyps (CRSwNP)Active Control1 Intervention
Group IV: Control Group 2: -no loss of smell / no CRS/no polypsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+